The Cigna Group stock heads into November 5 earnings release
Published on 11/04/2026 at 13:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat Investors Should Watch Next
- The Cigna Group will publish third-quarter 2026 results before the U.S. market opens on Thursday.
- Management will discuss the figures during an earnings call scheduled for 8:30 a.m. Eastern Time.
- The release will cover operations marketed through Cigna Healthcare and Evernorth Health Services.
The Cigna Group will publish its third-quarter 2026 financial results on Thursday, November 5, before 6:30 a.m. Eastern Time. The company announced the schedule in a release carried by PR Newswire.
Results Arrive Before The Open
Management plans to review the results on a conference call beginning at 8:30 a.m. Eastern Time. The webcast will be available through the company's investor-relations website, while the financial release and supplement are scheduled to appear no later than 6:30 a.m. Eastern Time.
The call gives investors the next opportunity to assess performance across Cigna Healthcare and Evernorth Health Services, the businesses marketed under The Cigna Group. The company says it has sales capabilities in more than 30 markets and jurisdictions and more than 180 million customer relationships worldwide.
Stock Awaits The Earnings Catalyst
The Cigna Group stock traded at 263.30 euros on Lang & Schwarz at 1:15:38 p.m. CET on Wednesday, November 4, 2026. Investors can follow the real-time quote of The Cigna Group stock.
The November 5 release is the next scheduled company event for shareholders. Management's comments and the financial supplement will provide the first fresh quarterly operating figures and outlook signals for the period under review.
The Cigna Group At A Glance
- Company: The Cigna Group
- ISIN: US1255231003
- Stock: CI
- Latest quote: 263.30 euros on Lang & Schwarz at 1:15:38 p.m. CET, November 4, 2026
- Next event: Third-quarter 2026 results on November 5, 2026
The S&P 500 provides the relevant market backdrop for this U.S.-listed healthcare company; see current S&P 500 coverage.
